跳至主要内容
临床试验/CTRI/2025/04/084874
CTRI/2025/04/084874尚未招募2 期

A randomized controlled clinical study to compare the efficacy of dys-fizz tablet with hinguvachadi churna in the management of udavartini yonivyapad

Dr Divya Shingare1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2025年5月21日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
80
试验地点
1
主要终点
DYS-FIZZ tablet is more effective than hinguvachadi choorna in management of udavartini yonivyapad

研究概览

简要总结

Dysmenorrhea, or painful menstruation, affects approximately 70.1% of women in India. Understanding this condition is crucial for improving quality of life and daily functioning. While modern medicine offers temporary relief, Ayurveda provides a holistic approach, particularly through the study of Udavartini Yonivyapad, a type of dysmenorrhea linked to imbalanced Vata dosha. Ayurvedic treatments focus on addressing the root cause, such as balancing Vata through dietary changes, lifestyle modifications, and herbal remedies. This study aims to compare the effectiveness of DYS-fizz tablet and Hinguvachadi Churna in managing Udavartini Yonivyapad. The study will involve 80 patients diagnosed with dysmenorrhea, randomly divided into two groups, with each receiving one of the treatments for three months. Outcomes will be assessed using a range of criteria, including pain intensity, working ability, and menstrual symptoms. The research hopes to bridge Ayurvedic and modern treatments, offering more effective, personalized options for dysmenorrhea management.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • Diagnosed patients of Udavartini Yonivyapad ( Patients suffering from dysmenorrhea).
  • Patients suffering from dysmenorrhea for the past 3 or more consecutive cycles.

排除标准

  • Age below 18years and above 40 years.
  • Patient coming with chief complaints of painful menstruation with regular.
  • Females with irregular menstrual cycle.
  • Patients having congenital anomalies leading to dysmenorrhea.

结局指标

主要结局

DYS-FIZZ tablet is more effective than hinguvachadi choorna in management of udavartini yonivyapad

时间窗: BT- 0th Day | DT- 4th Day of 1st and 2nd cycle of Menstruation | AT- 12th Week | Treatment Duration- 1st 6days of expected munstruation date and 2days of menses for 2cycle | Assesment on 4th Day of menses | Final Assesment on 12th week

次要结局

  • Hinguvachadi choorna is equal effective as DYS-FIZZ tablet in udavartini yonivyapad(BT- 0th Day)

研究者

发起方
Dr Divya Shingare
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验